Dare Bioscience Inc
NASDAQ:DARE

Watchlist Manager
Dare Bioscience Inc Logo
Dare Bioscience Inc
NASDAQ:DARE
Watchlist
Price: 3.03 USD -2.88% Market Closed
Market Cap: 26.8m USD

Intrinsic Value

The intrinsic value of one DARE stock under the Base Case scenario is 17.32 USD. Compared to the current market price of 3.03 USD, Dare Bioscience Inc is Undervalued by 83%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DARE Intrinsic Value
17.32 USD
Undervaluation 83%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dare Bioscience Inc

Valuation History Unavailable

Historical valuation for DARE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare DARE to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DARE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Dare Bioscience Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dare Bioscience Inc

Current Assets 11.8m
Cash & Short-Term Investments 10.3m
Receivables 105.2k
Other Current Assets 1.4m
Non-Current Assets 6.8m
PP&E 5.7m
Other Non-Current Assets 1.1m
Efficiency

Free Cash Flow Analysis
Dare Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dare Bioscience Inc

Revenue
89.6k USD
Cost of Revenue
7.6k USD
Gross Profit
97.2k USD
Operating Expenses
-1.7m USD
Operating Income
-1.6m USD
Other Expenses
-45.7k USD
Net Income
-1.7m USD
Fundamental Scores

DARE Profitability Score
Profitability Due Diligence

Dare Bioscience Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Exceptional Revenue Growth Forecast
ROE is Increasing
52/100
Profitability
Score

Dare Bioscience Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

DARE Solvency Score
Solvency Due Diligence

Dare Bioscience Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
48/100
Solvency
Score

Dare Bioscience Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DARE Price Targets Summary
Dare Bioscience Inc

Wall Street analysts forecast DARE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DARE is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

Lowest
Price Target
12.12 USD
300% Upside
Average
Price Target
13.26 USD
338% Upside
Highest
Price Target
14.7 USD
385% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dare Bioscience Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DARE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DARE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DARE stock?

The intrinsic value of one DARE stock under the Base Case scenario is 17.32 USD.

Is DARE stock undervalued or overvalued?

Compared to the current market price of 3.03 USD, Dare Bioscience Inc is Undervalued by 83%.

Back to Top